Bank of America
AST.WS

Bank of America’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

Bank of America’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-180
Closed – – 7584
2017
Q2 		$0 Buy
180
+11
+7% +$5 ﹤0.01% 7467
2017
Q1 		$0 Sell
169
-2
-1% -$1 ﹤0.01% 7601
2016
Q4 		$0 Buy
171
+2
+1% +$1 ﹤0.01% 7731
2016
Q3 		$0 Hold
169
– – ﹤0.01% 7724
2016
Q2 		$0 Buy
+169
New +$88 ﹤0.01% 7776

Bank of America's AST.WS Position: Q3 2017 in Review

Bank of America sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 180 shares.

Bank of America first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • Bank of America reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • Bank of America sold 180 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • Bank of America first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • Bank of America's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on Bank of America's 13F filing for Q3 2017, filed 14 Nov 2017.